JUL 22, 2019 9:45 AM PDT

Don't Combine Breast and Gyno Surgery, Study Advises

WRITTEN BY: Julia Travers

Surgeries can be stressful and difficult for patients, and it’s understandable that some would want to reduce the number of days they need to devote to surgical procedures. This desire has led some women to choose to combine breast and gynecologic procedures, such as cancer-preventive breast surgeries, hysterectomy and/or ovarian removal, into a single hospital visit. But, a new study out of the University of Colorado (CU) Cancer Center recently published in Breast Journal advises against this practice. This recommendation is based on an analysis of data from the National Surgery Quality Improvement Program (NSQIP) database.

The researchers involved found several negative trends associated with doubling up on these surgeries, including higher complication, readmission, and reoperation rates, a much longer length of stay at the hospital (compared to patients who had a single site surgery). These findings were drawn from the records of 77,030 women who had breast surgery between 2011 and 2015, 124 of whom also had a gynecologic surgery at the same time. Usually, younger women made this choice, but this group still showed the higher rate of surgery complications. 

“In patients at high risk of developing breast cancer and ovarian cancer, we recommend doing the prophylactic bilateral mastectomy along with breast reconstruction, but then trying to keep gynecologic surgery separate. It's safer and easier to do them separately," Dr. Sarah Tevis, CU Cancer Center investigator and breast surgeon at UC Health University of Colorado Hospital, told EurekAlert

Treatment delays tied to scheduling difficulties are also sometimes associated with combining surgical procedures. And, complications can delay the start of chemo for some patients, which has further ramifications. 

Tevis points out that, for some patients, a medical condition may make combining surgeries and only undergoing anesthesia once preferable. But she describes these cases as “rare.” Further research on these topics will attempt to identify which women will have better or worse reactions to the various surgical scheduling approaches. 

Article source: EurekAlert | Breast Enhancement Pills |

About the Author
You May Also Like
JUL 11, 2022
Cancer
Boosting CAR T Cell Therapy with TIGIT Blockade
JUL 11, 2022
Boosting CAR T Cell Therapy with TIGIT Blockade
Chimeric antigen receptor (CAR) T Cell therapy has emerged as a promising immunotherapeutic approach to treat blood canc ...
AUG 22, 2022
Immunology
A Lifetime of Mutations is Seen in Aging Immune Cells
AUG 22, 2022
A Lifetime of Mutations is Seen in Aging Immune Cells
Researchers have used advanced sequencing techniques to analyze immune cells in great detail. This work has shown that o ...
SEP 13, 2022
Immunology
How Cell 'Waste' Boosts Immune Cells' Fight Against Cancer
SEP 13, 2022
How Cell 'Waste' Boosts Immune Cells' Fight Against Cancer
It seems there is a lot more to lactate than we knew.
SEP 19, 2022
Cancer
Smoking Cessation Impacted by the COVID Pandemic
SEP 19, 2022
Smoking Cessation Impacted by the COVID Pandemic
Smoking remains a major risk factor for several types of cancer.  While the association between lung cancer and smo ...
OCT 04, 2022
Cancer
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
OCT 04, 2022
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
In August, President Biden announced his intention to appoint Dr. Monica M. Bertagnolli as the newest director of the Na ...
NOV 09, 2022
Genetics & Genomics
Want to Study Copy Number Alterations in Cells? Bring MACHETE
NOV 09, 2022
Want to Study Copy Number Alterations in Cells? Bring MACHETE
Sure, MACHETE is a cool name, but the researchers that developed the technique are hoping people don't focus solely on t ...
Loading Comments...